Pages that link to "Q33636704"

The following pages link to Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). (Q33636704):

Displayed 50 items.

• Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy (Q26739711) ‎ (← links)
• A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts (Q26741164) ‎ (← links)
• Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders (Q26765419) ‎ (← links)
• Regulation of the Intestinal Barrier Function by Host Defense Peptides (Q26776055) ‎ (← links)
• Intracellular Mono-ADP-Ribosylation in Signaling and Disease (Q26783018) ‎ (← links)
• The Role of Calcium and Cyclic AMP in PKD (Q26824644) ‎ (← links)
• GSK3β and the control of infectious bacterial diseases (Q27013766) ‎ (← links)
• Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders (Q27027115) ‎ (← links)
• The importance of Wnt signalling for neurodegeneration in Parkinson's disease (Q28115237) ‎ (← links)
• Methane limit LPS-induced NF-κB/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K/AKT/GSK-3β-mediated IL-10 expression (Q28383990) ‎ (← links)
• Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis (Q28484135) ‎ (← links)
• Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases (Q28509645) ‎ (← links)
• The combination effects of licl and the active leflunomide metabolite, A771726, on viral-induced interleukin 6 production and EV-A71 replication (Q28545087) ‎ (← links)
• PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome (Q30315106) ‎ (← links)
• Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology (Q30472080) ‎ (← links)
• Glycogen synthase kinase-3 in the etiology and treatment of mood disorders (Q30474415) ‎ (← links)
• From Shortage to Surge: A Developmental Switch in Hippocampal-Prefrontal Coupling in a Gene-Environment Model of Neuropsychiatric Disorders (Q30823297) ‎ (← links)
• Differences in neural-immune gene expression response in rat spinal dorsal horn correlates with variations in electroacupuncture analgesia (Q31082369) ‎ (← links)
• ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology (Q33589732) ‎ (← links)
• Oxidative stress promotes D-GalN/LPS-induced acute hepatotoxicity by increasing glycogen synthase kinase 3β activity (Q33600191) ‎ (← links)
• Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation (Q33661598) ‎ (← links)
• Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease. (Q33771694) ‎ (← links)
• Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice (Q33797938) ‎ (← links)
• Abscisic acid induces a transient shift in signaling that enhances NF-κB-mediated parasite killing in the midgut of Anopheles stephensi without reducing lifespan or fecundity. (Q33901075) ‎ (← links)
• PI3K-dependent GSK3ß(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response (Q34062362) ‎ (← links)
• Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome (Q34142731) ‎ (← links)
• Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways (Q34220376) ‎ (← links)
• Glycogen synthase kinase 3β (GSK3β) modulates antiviral activity of zinc-finger antiviral protein (ZAP). (Q34238255) ‎ (← links)
• Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. (Q34550268) ‎ (← links)
• Signaling pathways activated by a protease allergen in basophils (Q34581292) ‎ (← links)
• The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. (Q34670501) ‎ (← links)
• Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits (Q34731214) ‎ (← links)
• Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. (Q34778497) ‎ (← links)
• 4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells (Q34854412) ‎ (← links)
• Membrane-to-nucleus signaling links insulin-like growth factor-1- and stem cell factor-activated pathways (Q35014924) ‎ (← links)
• Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells (Q35075106) ‎ (← links)
• Protection against Klebsiella pneumoniae using lithium chloride in an intragastric infection model (Q35076884) ‎ (← links)
• A20 is critical for the induction of Pam3CSK4-tolerance in monocytic THP-1 cells (Q35086715) ‎ (← links)
• Akt-mediated proinflammatory response of mononuclear phagocytes infected with Burkholderia cenocepacia occurs by a novel GSK3β-dependent, IκB kinase-independent mechanism. (Q35091346) ‎ (← links)
• Decreased store operated Ca2+ entry in dendritic cells isolated from mice expressing PKB/SGK-resistant GSK3. (Q35093703) ‎ (← links)
• Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response (Q35108092) ‎ (← links)
• Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism (Q35131974) ‎ (← links)
• Kinase activity profiling of gram-negative pneumonia (Q35136658) ‎ (← links)
• GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke (Q35154467) ‎ (← links)
• Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders (Q35197096) ‎ (← links)
• Neuroprotective action of lithium in disorders of the central nervous system (Q35212429) ‎ (← links)
• Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease (Q35356604) ‎ (← links)
• Glycogen synthase kinase 3β ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production (Q35407394) ‎ (← links)
• Cytokine-induced monocyte MMP-1 is negatively regulated by GSK-3 through a p38 MAPK-mediated decrease in ERK1/2 MAPK activation (Q35430731) ‎ (← links)
• Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter (Q35509305) ‎ (← links)